Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?

Journal of Inflammation

Volumn 5, Issue , 2008, Pages

  Shankar, Esaki Muthu ^a   Vignesh, Ramachandran ^a   Velu, Vijayakumar ^a   Murugavel, Kailapuri G ^a   Sekar, Ramalingam ^a   Balakrishnan, Pachamuthu ^a   Lloyd, Charmaine A C ^a   Saravanan, Shanmugam ^a   Solomon, Suniti ^a   Kumarasamy, Nagalingeswaran ^a  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

BINDING AFFINITY; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; DISEASE COURSE; DISEASE PREDISPOSITION; EFFECTOR CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; INFLAMMATION; MEMORY T LYMPHOCYTE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 40549123998     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-5-2     Document Type: Review

References (50)

1. Incidence of immune reconstitution syndrome in HIV/tuberculosis- coinfected patients after initiation of generic antiretroviral therapy in India. N Kumarasamy S Chaguturu KH Mayer S Solomon HT Yepthomi P Balakrishnan, J Acquir Immune Defic Syndr 2004 37 1574 1576 10.1097/00126334-200412150-00007 15577411
2. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. NM Keane P Price S Lee CA Almeida SF Stone I James MA French, HIV Med 2004 5 407 414 10.1111/j.1468-1293.2004.00245.x 15544692
3. Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpes virus-associated immune restoration disease after start of highly active antiretroviral therapy. SF Stone P Price J Brochier MA French, J Infect Dis 2001 184 1073 1077 10.1086/323599 11574925
4. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. CE Koval F Gigliotti D Nevins LM Demeter, Clin Infect Dis 2002 35 491 493 10.1086/341974 12145736
5. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. T Bicanic T Harrison A Niepieklo N Dyakopu G Meintjes, Clin Infect Dis 2006 43 1069 1073 10.1086/507895 16983622
6. Pyomyositis and cutaneous abscesses due to Mycobacterium avium : an immune reconstitution manifestation in a patient with AIDS. SD Lawn TA Bicanic DC Macallan, Clin Infect Dis 2004 38 461 463 10.1086/381033 14727228
7. Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy. I Sereti NJ Sarlis E Arioglu ML Turner JM Mican, AIDS 2001 15 138 140 10.1097/00002030-200101050- 00026 11192862
8. Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome. P Mirmirani TA Maurer B Herndier M McGrath MD Weinstein TG Berger, J Am Acad Dermatol 1999 41 285 286 10.1016/S0190-9622(99)70364-6 10426909
9. Acute bilateral parotitis caused by Mycobacterium scrofulaceum : immune reconstitution disease in a patient with AIDS. SD Lawn A Checkley MH Wansbrough-Jones, Sex Transm Infect 2005 81 517 518 10.1136/sti.2005.014993 16326858
10. Immune reconstitution syndrome to Strongyloides stercoralis infection. CL Taylor V Subbarao S Gayed AP Ustianowski, AIDS 2007 21 649 650 17314529
11. Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: Views over hidden possibilities. EM Shankar R Vignesh KG Murugavel P Balakrishnan CA Lloyd R Sekar S Solomon N Kumarasamy, AIDS Res Ther 2007 4 29 18053126 10.1186/1742-6405-4-29
12. Immune reconstitution inflammatory syndrome: more answers, more questions. SA Shelburne M Montes RJ Hamill, J Antimicrob Chemother 2006 57 167 170 10.1093/jac/dki444 16354748
13. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. A Bourgarit G Carcelain V Martinez C Lascoux V Delcey B Gicquel E Vicaut PH Lagrange D Sereni B Autran, AIDS 2006 20 F1 F7 16511406
14. Clinical profile of HIV in India. N Kumarasamy S Vallabhaneni TP Flanigan KH Mayer S Solomon, Indian J Med Res 2005 121 377 394 15817951
15. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. S Shelburne F Visnegarwala J Darcourt E Graviss T Giordano AC White Jr RJ Hamill, AIDS 2005 19 399 406 10.1097/01.aids.0000161769.06158.8a 15750393
16. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. RP Bucy RD Hockett CA Derdeyn MS Saag K Squires M Sillers RT Mitsuyasu JM Kilby, J Clin Invest 1999 103 1391 1398 10330421 10.1172/JCI5863
17. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. B Autran G Carcelain TS Li C Blanc D Mathez R Tubiana C Katlama P Debré J Leibowitch, Science 1997 277 112 116 10.1126/science.277.5322.112 9204894
18. Immune reconstitution syndrome in a child with TB and HIV. G Narendran S Swaminathan S Sathish S Rajasekaran, Indian J Pediatr 2006 73 627 629 10.1007/BF02759931 16877860
19. Immune reconstitution syndrome following initiation of antiretroviral therapy in HIV and multidrug resistant tuberculosis. S Swaminathan C Padmapriya G Narendran B Thomas S Anand A Rajalakshmi, Indian J Chest Dis Allied Sci 2005 47 299 304 16255403
20. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. T Wendland H Furrer PL Vernazza K Frutig A Christen L Matter WJ MPichler, AIDS 1999 13 1857 1862 10.1097/00002030-199910010-00007 10513643
21. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. S Sakaguchi N Sakaguchi M Asano M Itoh M Toda, J Immunol 1995 155 1151 1164 7636184
22. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. S Sakaguchi N Sakaguchi J Shimizu S Yamazaki T Sakihama M Itoh Y Kuniyasu T Nomura M Toda T Takahashi, Immunol Rev 2001 182 18 32 10.1034/j.1600-065X.2001.1820102.x 11722621
23. Suppressor T cells: Rebirth, function and homeostasis. EM Shevach, Curr Biol 2000 10 R572 R575 10.1016/S0960-9822(00)00617-5 10959833
24. low CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. F Powrie R Correa-Oliveira S Mauze RL Coffman, J Exp Med 1994 179 589 600 10.1084/jem.179.2.589 7905019
25. Regulatory T cells in the control of immune pathology. KJ Maloy F Powrie, Nat Immunol 2001 2 816 822 10.1038/ni0901-816 11526392
26. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. C Asseman S Mauze MW Leach RL Coffman F Powrie, J Exp Med 1999 190 995 1004 10.1084/jem.190.7.995 10510089
27. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. S Read V Malmstrom F Powrie, J Exp Med 2000 192 295 302 10.1084/jem.192.2.295 10899916
28. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. T Takahashi T Tagami S Yamazaki T Uede J Shimizu N Sakaguchi TW Mak S Sakaguchi, J Exp Med 2000 192 303 310 10.1084/jem.192.2.303 10899917
29. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor b and interleukin 4 in the prevention of autoimmune thryroiditis in rats by peripheral CD4+ CD45RC- cells and CD4+ CD8- thymocytes. B Seddon D Mason, J Exp Med 1999 89 279 288 10.1084/jem.189.2.279
30. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. F Powrie J Carlino MW Leach S Mauze RL Coffman, J Exp Med 1996 183 2669 2674 10.1084/jem.183.6.2669 8676088
31. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. K Nakamura A Kitani W Strober, J Exp Med 2001 194 629 644 10.1084/jem.194.5.629 11535631
32. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. EA Green L Gorelik CM McGregor EH Tran RA Flavell, Proc Natl Acad Sci USA 2003 100 10878 10883 12949259 10.1073/pnas.1834400100
33. CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. T Oida X Zhang M Goto S Hachimura M Totsuka S Kaminogawa HL Weiner, J Immunol 2003 170 2516 2522 12594277
34. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. A Sundstedt EJ O'Neill KS Nicolson DC Wraith, J Immunol 2003 170 1240 1248 12538682
35. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. H Groux A O'Garra M Bigler M Rouleau S Antonenko JE de Vries MG Roncarolo, Nature 1997 389 737 742 10.1038/39614 9338786
36. Type 1 T regulatory cells. MG Roncarolo R Bacchetta C Bordignon S Narula MK Levings, Immunol Rev 2001 182 68 79 10.1034/j.1600-065X.2001.1820105.x 11722624
37. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Buer A Lanoue A Franzke C Garcia H von Boehmer A Sarukhan, J Exp Med 1998 187 177 183 10.1084/jem.187.2.177 9432975
38. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. FJ Barrat DJ Cua A Boonstra DF Richards C Crain HF Savelkoul R de Waal-Malefyt RL Coffman CM Hawrylowicz A O'Garra, J Exp Med 2002 195 603 616 10.1084/jem.20011629 11877483
39. Natural CD4 CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10. C Pontoux A Banz M Papiernik, Int Immunol 2002 14 233 239 10.1093/intimm/14.2.233 11809742
40. IL-10 secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occuring CD4+CD25+ regulatory T cells. PL Vieira JR Christensen S Minaee EJ O'Neill FJ Barrat A Boonstra T Barthlott B Stockinger DC Wraith A O'Garra, J Immunol 2004 172 5986 5993 15128781
41. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. HL Weiner, Immunol Today 1997 18 335 343 10.1016/S0167-5699(97)01053-0 9238837
42. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. EM Aandahl J Michaelsson WJ Moretto FM Hecht DF Nixon, J Virol 2004 78 2454 2459 14963140 10.1128/JVI.78.5.2454-2459.2004
43. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. VA Boussiotis EY Tsai EJ Yunis S Thim JC Delgado CC Dascher A Berezovskaya D Rousset JM Reynes AE Goldfeld, J Clin Invest 2000 105 1317 1325 10792007 10.1172/JCI9918
44. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4 and CD8 HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. AL Kinter M Hennessey A Bell S Kern Y Lin M Daucher M Planta M McGlaughlin R Jackson SF Ziegler AS Fauci, J Exp Med 2004 200 331 343 10.1084/jem.20032069 15280419
45. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. K Oswald-Richter SM Grill N Shariat M Leelawong MS Sundrud DW Haas D Unutmaz, PLoS Biol 2004 2 E198 15252446 10.1371/journal.pbio.0020198
46. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. D Xu H Liu M Komai-Koma C Campbell C McSharry J Alexander FY Liew, J Immunol 2003 170 394 399 12496424
47. Regulation of immunity to parasites by T cells and T cell-derived cytokines. A Sher RL Coffman, Annu Rev Immunol 1992 10 385 409 10.1146/annurev.iy.10.040192.002125 1590992
48. Development and function of T helper 1 cells. A O'Garra D Robinson, Adv Immunol 2004 83 133 162 15135630
49. Cytokines induce the development of functionally heterogeneous T helper cell subsets. A O'Garra, Immunity 1998 8 275 283 10.1016/S1074-7613(00)80533-6 9529145
50. Interleukin-10 and the interleukin-10 receptor. KW Moore R de Waal Malefyt RL Coffman A O'Garra, Annu Rev Immunol 2001 19 683 765 10.1146/annurev.immunol.19.1.683 11244051